Doudna Speaks Out on Multimillion-Dollar Pricetags for Revolutionary Cures
Thorny questions and taxpayer dollars: Can the California stem cell agency come up with solutions?
“How do we make sure that a technology like CRISPR — you know, no offense intended — is not just going to make a few people rich?”
That’s the question posed earlier this month by Nobel Prize-winning scientist Jennifer Doudna as she spoke to a group of executives and investors. What she had to say bears directly on a hos…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.